PHARMACEUTICAL SERVICES

meet us at
Oct. 25th - 27th - 2011
CPHI Frankfurt - Germany
March 12th - 15th - 2012
DCAT New York - USA

LAST NEWS
2011 - Certificate of GMP compliance of a Manufacturer for Human investigational medicinal product

2011 - Certificate of GMP compliance of a Manufacturer for Human medicinal product

MAA CESSION & TRANSFER
Licensing-out opportunity Cetirizine 10 mg/ml, oral solution (NL33352)
NEW MAA CESSION & TRANSFER
Licensing-out opportunity Donepezil 5 mg, ODT (NL37771) and Donepezil 10 mg, ODT (NL37772)
2009 - cGMP Agreement for human use

Galenix Pharma has obtained an updated agreement for cGMP manufacturing, importation and ditribution of human and investigational medicinal products AFSSAPS #M09/168
2008 - cGMP Agreement for veterinary use

Galenix Pharma has obtained an agreement for cGMP manufacturing, importation and distribution of veterinary and investigational medicinal products AFSSA #V1515/08
MAA CESSION & TRANSFER
Licensing-out opportunity Fenofibrate 67 mg, tablet (NL27271) - Fenofibrate 200 mg, tablet (NL27274) and Fenofibrate 160 mg, modified release tablet (NL31360)

newsletter signup
Subscribe Newsletter Please insert your email adress


indentification user
Forgot password Register

Every day we are investing in innovative solutions and technologies, we optimize the drug product development process allowing our clients to introduce a marketing difference and improvement of the patient compliance.

Time is of the essence in pharmaceutical development and a perfectly managed project coordination is the key to success in time.

On the other hand, developing a new drug product takes several months to several years and during that time, regulations change.

For these two reasons, all projects are managed by the Regulatory Affairs teams assuring that both, customer's requirements and the most recent regulations are constantly implemented.
Green light !
Home - About us - Pharmaceutical Services - Clinical Supplies - Drug delivery - Business Opportunities - News - Job offers - Contact
Copyright © 2010 Galenix - Tous droits réservés